Literature DB >> 3258963

Effective preoperative irradiation of highly vascular cerebellopontine angle neurinomas.

K Ikeda1, H Ito, K Kashihara, H Fujisawa, S Yamamoto.   

Abstract

Three cases of large cerebellopontine angle neurinoma with marked vascularity and tumor staining on the angiogram were treated with effective preoperative irradiation. The radiotherapy was given before the second operation in two cases and before the first operation in the other case. Irradiation doses administered with a linear accelerator were 2.34 to 3.0 Gy for 3 to 3.5 weeks, and radical operations were done 1.5 to 2 months after irradiation. After the irradiation, vertebral angiography showed moderate to marked decrease of the hypervascular capsular stain and disappearance of the early draining vein. Computed tomographic scan showed enlargement of the central necrotic area within the heterogeneously enhanced tumor, which was unchanged in size. Radical operations, which had been impossible because of uncontrollable massive bleeding, were successful without any intraoperative bleeding after radiotherapy. Postirradiation radiological findings corresponded well with those of histopathological examination, which showed decrease in cellularity and in vascularity and diffuse coagulation necrosis around the collapsed tumoral vessels as radiation effects. Preoperative irradiation of the hypervascular neurinoma was though to facilitate radical surgery by abolishing or diminishing the risk of intraoperative bleeding.

Entities:  

Mesh:

Year:  1988        PMID: 3258963     DOI: 10.1227/00006123-198803000-00022

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  1 in total

1.  Arterial spin labeling imaging correlates with the angiographic and clinical vascularity of vestibular schwannomas.

Authors:  Yujiro Tanaka; Michihiro Kohno; Takao Hashimoto; Nobuyuki Nakajima; Hitoshi Izawa; Hirofumi Okada; Norio Ichimasu; Ken Matsushima; Tomoya Yokoyama
Journal:  Neuroradiology       Date:  2020-01-09       Impact factor: 2.804

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.